Gelsolin suppresses tumorigenicity through inhibiting PKC activation in a human lung cancer cell line, PC10

N Sagawa1, H Fujita, Y Banno

  • 1Division of Cancer Gene Regulation, Research Section of Disease Control, Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan.

British Journal of Cancer
|February 20, 2003
PubMed

Insights

Restoring gelsolin in lung cancer cells significantly reduced tumor formation and cell growth. Gelsolin also blocked bradykinin-stimulated signaling pathways crucial for cancer cell proliferation and tumorigenicity.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Gelsolin is downregulated in various human cancers, including lung cancer.
  • Gelsolin's role in regulating cancer cell growth and tumorigenicity requires further investigation.

Purpose of the Study:

  • To investigate the impact of gelsolin restoration on lung cancer cell tumorigenicity and proliferation.
  • To explore the effect of gelsolin on bradykinin-induced signaling pathways involving phospholipase C (PLC) and protein kinase C (PKC).

Main Methods:

  • Stable expression of gelsolin in a human lung squamous cell carcinoma line (PC10) via gene transfer.
  • In vitro assessment of cell proliferation and in vivo evaluation of tumorigenicity in nude mice.
  • Analysis of bradykinin-induced phosphatidylinositol 4,5-bisphosphate (PIP2) hydrolysis, inositoltriphosphate (IP3) production, and PKC isoform translocation.

Main Results:

  • Gelsolin-overexpressing lung cancer cells exhibited significantly reduced tumorigenicity and repressed cell proliferation compared to controls.
  • Bradykinin failed to induce IP3 production and PKC alpha/gamma translocation in gelsolin transfectants.
  • Bradykinin-induced PIP2 hydrolysis and PKC translocation were observed in parental and control cells but not in gelsolin-expressing cells.

Conclusions:

  • Gelsolin restoration suppresses lung cancer cell proliferation and tumorigenicity.
  • Gelsolin inhibits bradykinin-stimulated PLC/PKC signaling pathways, which are critical for cell growth and cancer development.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...